Qing Yang, MD, MS Associate Professor

Photo of Qing Yang
MRB 2.143C (O) | 2.164 &166 (L)
Tel: (409) 772-1802 | Fax: (409) 762-9382 
qiyang@utmb.edu

Education and Training

 

My research mainly focuses on elucidating the cellular and molecular mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN), with particular emphasis on the role of peripheral axonal mitophagy in sensory neuron degeneration and chronic pain.

To address critical gaps in our understanding of CIPN pathogenesis, my laboratory employs a multidisciplinary approach integrating chemogenetics, transmission electron microscopy, super-resolution confocal imaging, RNA sequencing, electrophysiology (in vivo, ex vivo, and in vitro), real-time imaging, immunohistochemistry, and behavioral neuroscience. Through these complementary approaches, we seek to define the molecular and cellular events that initiate and drive peripheral nerve degeneration, sensory dysfunction, and chronic pain following chemotherapy.

My current and future research program centers on three major areas:

1. Mechanisms underlying the characteristic “stocking-and-glove” sensory dysfunction of CIPN. We seek to identify the cellular and molecular determinants responsible for the unique distal pattern of sensory neuron injury observed in cancer patients receiving chemotherapy.

2. Neuroimmune regulation of CIPN. We investigate how perineural immune cells, particularly mast cells, contribute to chemotherapy-induced nerve injury, neuroinflammation, and chronic pain.

3. Gut microbiome–sensory neuron interactions in CIPN. We aim to define how gut microbiota regulates sensory neuron function, influence individual susceptibility to CIPN, and serve as a source of predictive biomarkers and therapeutic targets.

Beyond CIPN, my long-term research interests extend to the emerging fields of cancer neuroscience and cancer pain, with the goal of understanding how interactions among tumors, the nervous system, and the immune system influence disease progression, treatment response, and patient quality of life.

A second major research area is neuroprotection and regeneration following spinal cord injury (SCI). Our work examines how dura mast cell activation, and neuroimmune communication influence neuronal survival, functional recovery, and long-term neurobehavioral outcomes after injury. These studies aim to uncover therapeutic targets that enhance neural repair and improve recovery after SCI.

Through these efforts, the Yang Laboratory seeks to advance the understanding of nervous system disorders and accelerate the development of mechanism-based therapies for neuropathy, chronic pain, and neurological injury.